Cargando…
Monitoring of Intracellular Tau Aggregation Regulated by OGA/OGT Inhibitors
Abnormal phosphorylation of tau has been considered as a key pathogenic mechanism inducing tau aggregation in multiple neurodegenerative disorders, collectively called tauopathies. Recent evidence showed that tau phosphorylation sites are protected with O-linked β-N-acetylglucosamine (O-GlcNAc) in n...
Autores principales: | Lim, Sungsu, Haque, Md. Mamunul, Nam, Ghilsoo, Ryoo, Nayeon, Rhim, Hyewhon, Kim, Yun Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613198/ https://www.ncbi.nlm.nih.gov/pubmed/26343633 http://dx.doi.org/10.3390/ijms160920212 |
Ejemplares similares
-
Identification of disulfide cross-linked tau dimer responsible for tau propagation
por: Kim, Dohee, et al.
Publicado: (2015) -
The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome
por: Zuliani, Ilaria, et al.
Publicado: (2020) -
Cell-based Models To Investigate Tau Aggregation
por: Lim, Sungsu, et al.
Publicado: (2014) -
Antioxidant Compound, Oxyresveratrol, Inhibits APP Production through the AMPK/ULK1/mTOR-Mediated Autophagy Pathway in Mouse Cortical Astrocytes
por: Rahman, Md. Ataur, et al.
Publicado: (2021) -
Cryo-EM structure of human O-GlcNAcylation enzyme pair OGT-OGA complex
por: Lu, Ping, et al.
Publicado: (2023)